CSS-02 - Frontline Opioid Prescribing: Rebalancing Benefit-Risk to Improve Outcomes

8:15am-8:30am Breakfast and Registration
8:30am-9:30am CME Symposium

Link to register: https://singuser3bf024cb.iad1.qualtrics.com/jfe/form/SV_2c1ixzWI2W7OBMi

The faculty will provide healthcare professionals (HCPs) with essential information on the need for appropriate pain management to help broaden and enhance patient advocacy, with the goal of ensuring that patients receive the treatments they need to achieve effective chronic pain control and improved functionality. This may include the use of opioids, when deemed appropriate following an initial evaluation and risk stratification, as part of a tailored treatment plan that incorporates continuous, long-term assessment and monitoring.

The faculty will explain the pharmacologic rationale for prescribing opioids with safety advantages that surpass traditional formulations while delivering equivalent pain relief, thus enhancing HCP-patient communication about benefits and risks. Addressing persistent misconceptions, the faculty will provide clinical recommendations for the safe and effective use of buprenorphine in chronic pain management and critically evaluate key differences between abuse-deterrent formulation (ADF) opioids to aid clinicians in making informed benefit-risk assessments and selecting suitable opioids for patients suffering with chronic pain. Given the current challenges in pain management, which have been exacerbated by the opioid crisis, this education is crucial to the dual effort of aiding patients struggling to access adequate care, and providing clinicians with clinical data to support their recommendations when faced with heightened scrutiny surrounding opioids for the treatment of chronic pain.

Breakfast will be provided. This session is certified for credit.